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Abstract
Cigarette smoking has been proposed as a major risk factor for aging-related pathological changes and Alzheimer’s disease
(AD). To date, little is known for how smoking can predispose our brains to dementia or cognitive impairment. This study
aimed to investigate the cigarette smoke-induced pathological changes in brains. Male Sprague-Dawley (SD) rats were
exposed to either sham air or 4% cigarette smoke 1 hour per day for 8 weeks in a ventilated smoking chamber to mimic the
situation of chronic passive smoking. We found that the levels of oxidative stress were significantly increased in the
hippocampus of the smoking group. Smoking also affected the synapse through reducing the expression of pre-synaptic
proteins including synaptophysin and synapsin-1, while there were no changes in the expression of postsynaptic protein
PSD95. Decreased levels of acetylated-tubulin and increased levels of phosphorylated-tau at 231, 205 and 404 epitopes
were also observed in the hippocampus of the smoking rats. These results suggested that axonal transport machinery might
be impaired, and the stability of cytoskeleton might be affected by smoking. Moreover, smoking affected amyloid precursor
protein (APP) processing by increasing the production of sAPPb and accumulation of b–amyloid peptide in the CA3 and
dentate gyrus region. In summary, our data suggested that chronic cigarette smoking could induce synaptic changes and
other neuropathological alterations. These changes might serve as evidence of early phases of neurodegeneration and may
explain why smoking can predispose brains to AD and dementia.
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Introduction
Epidemiological studies have shown that cigarette smoking is an
important risk factor of cognitive decline and AD, the most
common form of dementia [1–3]. Cigarette smoking not just
doubles the risk of developing dementia and AD [4]; it also
accelerates the rate of cognitive decline in elderly without
dementia [2]. Apart from active smoking, recent study shows that
exposure to secondhand smoke i.e. passive smoking can also
increase the odds of developing cognitive impairment [5]. Subjects
who have been exposed to secondhand smoke for more than 25
years and have history of carotid artery stenosis have a 3-fold
increased risk for dementia [6]. Although these studies suggest a
linkage between cigarette smoking (both active and passive) and
cognitive impairment, there is insufficient experimental data
demonstrating how smoking induces cognition-related patholog-
ical changes. In fact, early studies on human autopsy samples
demonstrated conflicting results for the association between
smoking and AD-neuropathological changes. For example,
Sabbagh and colleagues had studied the association between
smoking and AD in never, former and active smokers followed to
AD autopsy. They found that smoking had no significant influence
on AD neuropathology (Braak stage, neurofibrillary tangles, total
plaques and neuritic plaques) regardless of AP0E f4 status,
although higher levels of smoking were associated with shorter
disease duration [7]. However, in another study conducted by
Ulrich and colleagues, it was found that the amount of smoking
was positively correlated with the neurofibrillary changes as
expressed in Braak stages in smokers [8]. Tyas and colleagues also
reported that former smokers had more neuritic plaques in the
neocortex and the hippocampus than never smokers [9]. Although
the presence of senile plaques and neurofibrillary tangles has been
widely accepted as neuropathological hallmarks of AD, it is worth
to notice that the number of senile plaques is not associated with
duration and severity of dementia [10,11]. On the other hand,
synaptic pathology was closely associated to the clinical dementia
in AD [10,12]. Therefore other indicators apart from senile
plaques and neurofibrillary tangles may be included to better study
the relationship between smoking and neuropathological changes
in AD.
For a long time, cigarette smoking has been known as an
important environmental aging accelerator [13,14] partly because
it induces oxidative stress in multiple organs including the brain
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36752[15]. During the combustion of a cigarette, more than 4000
chemicals are produced, in which many of them are reactive
radicals. These reactive radicals modify biomolecules through
oxidation reaction, resulting in defective cellular signaling and
accumulation of malfunctioned proteins [16]. A number of reports
have shown that oxidative stress was found in the brains of
cigarette smoke exposed-animals [17,18]. However, oxidative
stress can be generally found in many diseases, thus more
cognition-related or neurodegeneration-related pathological
changes should be presented to demonstrate a direct linkage
between smoking and AD.
In this study, we adopted a passive smoking model in which rats
were exposed to sham air or cigarette smoke 1 h daily for 8 weeks.
We investigated if exposure to cigarette smoke could induce
oxidative stress and early pathological changes that are related to
cognitive impairment or development of AD. Since synaptic
degeneration is an early event during normal aging and AD [19–
21], we detected changes in synapse by measuring the levels of
synaptic proteins synapsin-1, synaptophysin and PSD95. Stability
of the spine and functions of axonal transport were elevated by
measuring the expression of drebrin and acetylated-tubulin. The
early pathological changes of AD were evaluated by measuring the
levels of beta-amyloid (Ab) peptide and hyperphosphorylation of
the tau protein. Our data suggested that exposure to cigarette
smoke could induce oxidative stress, changes in synaptic proteins
and pre-AD-like pathological changes which might partly explain
why passive cigarette smoking is harmful to the brain.
Materials and Methods
Antibodies and chemicals
Mouse monoclonal antibody against 8 hydroxyguanosine (8-
OHG) (recognizes 8-hydroxy-29-deoxyguanosine, 8-hydroxygua-
nine and 8-hydroxyguanosine) was from Abcam (Cambridge,
UK). Rabbit polyclonal antibodies for tau pT231 against tau
phosphorylated at Thr231, tau pT205 against tau phosphorylated
at Thr205, tau pS396 against tau phosphorylated at Ser396 and
tau pS404 against tau phosphorylated at Ser 404 were purchased
from BioSource International (Hopkinton, MA, USA). Rabbit
polyclonal antibody against amyloid precursor protein (APP) was
from Novus Biologicals (Littleton, CO). Rabbit polyclonal
antibodies against phosphorylated ERK (P44/42), total ERK,
phosphorylated JNK (Thr183 or Tyr185), total JNK, cleaved
caspase-3, phosphorylated GSK-3b (Ser9) and mouse monoclonal
antibody against synapsin-1 were from Cell Signaling Technology
(Boston, MA, USA). Rabbit polyclonal antibody against PSD-95
was from Synaptic Systems (Go ¨ttingen, Germany). Mouse
monoclonal antibodies against acetylated-tubulin and a-tubulin
were from Sigma-Aldrich, Inc. (St. Louis, MO, USA). Mouse
monoclonal antibody against synaptophysin and rabbit polyclonal
antibody against rodent Ab were from Chemicon (Temecula, CA).
Rabbit polyclonal antibody against human sAPPb and mouse
polyclonal antibody against human sAPPa were from IBL
(Gunma, Japan). Secondary antibodies were horseradish peroxi-
dase-conjugated goat anti-rabbit and goat anti-mouse from
DAKO (Glostrup, Denmark). Alexa FluorH-488 goat anti-rabbit
IgG was purchased from Invitrogen (Carlsbad, CA). The protein
content assay kit and Polyvinylidene fluoride (PVDF) membrane
were purchased from Bio-Rad (Hercules, CA, USA). Enhanced
chemiluminescence (ECL) detection kit was from Amersham
(Buckinghamshire, UK). Rabbit polyclonal antibody against
human-tau (K9JA/ pan-tau) and anti-fade mounting medium
were from DAKO (USA). Mouse polycolonal antibody against
GSK3b phosphorylated at Tyr 216 was from BD Biosciences (San
Jose, CA, USA). Rabbit polyclonal antibody against PP2A
phosphorylated at Tyr307 was from Epitomics (CA, USA).
Animals
Nine male Sprague-Dawley rats (150–200 g) were purchased
from the Laboratory Animal Unit (LAU) of the LKS Faculty of
Medicine in the University of Hong Kong. The rats were
maintained in a temperature-controlled room with a 12-h light/
dark cycle throughout the observation period. The rats were
divided into two groups, with four rats in the control group, five
rats in the cigarette smoke (smoking) group. The control group
were exposed to sham air, while the smoking were exposed to 4%
cigarette smoke for 1 h daily with commercially available
cigarettes (Camel; filter, R.J. Reynolds, Winston-Salem, NC,
USA) for 56 days using the modified ventilated smoking exposure
chambers as previously described by Chow et al [22,23]. In brief,
the rats of the smoking group were housed in a ventilated 20-litre
chamber filled with smoke. The concentration of smoke was kept
constant at 4% (vol/vol, smoke/air) by using a peristaltic pump
(Masterflex; Cole-Parmer Instrument Co., Niles, IL, USA) to
deliver fresh cigarette smoke from burning cigarettes at a constant
rate (40 ml/min), while another pump was simultaneously used to
deliver fresh air from outside at a constant rate (960 ml/min) to
mix. Rats were exposed to 12 cigarettes in an hour daily. For the
control group, the rats were subjected to the same procedures in
another ventilated chamber but exposed only to fresh air (0%, vol/
vol, smoke/air) simultaneously. This cigarette smoking model was
proven to neither disturb the normal physiological functions of the
animals, such as acid/base balance and O2/CO2 in the blood,
heart rate and blood pressure, nor to impose any stress on the
animals. The body weight was similar between the control and
smoking groups [23]. After 56-day exposure, the rats were
euthanized by overdose of pentobarbitone. Their brains were
dissected for Western blot analysis and immunohistochemical
analysis. This protocol was approved by the Committee on the
Use of Live Animals in Teaching and Research (CULATR) of The
University of Hong Kong.
Immunohistochemical staining
Brain tissues were fixed in 4% paraformaldehyde for three days
and dehydrated in ethanol and embedded in paraffin. 6-mm-thick
coronal rat brain sections were cut. After dewaxing and
rehydration, the sections were treated with 0.01 M citrate buffer
(pH 6.0) with 0.1% Tween-20 at 90uC for 15 min for antigen
retrieval. For sections stained with Ab peptide, the sections were
treated with 88% formic acid for eight minutes after citric buffer
treatment. Sections were then washed in PBS three times then
blocked with 10% normal goat serum in PBS for 1 h. Sections
were incubated with primary antibody against 8-OHG (1:100),
synapsin-1 (1:400), acetylated-tubulin (1:800) or Ab peptide (1:100)
at 4uC overnight. After washing with PBS, the sections were
stained with secondary antibody, Alexa FluorH-488 for 2 h and
finally stained with DAPI to reveal the nuclei. Sections were then
mounted with anti-fade mounting medium. The sections were
examined with a Zeiss LSM510 confocal microscopic system (Carl
Zeiss, Jena GmbH, Jena, Germany).
Western blotting analysis
Total lysate was collected from rat hippocampus. In brief, tissue
samples were homogenized in ice-cold lysis buffer (10 mM Tris-
HCl (pH 7.4), 1 mM NaCl, 20 mM Na4P2O7, 2 mM Na3VO4,
1% Triton-X-100, 10% glycerol, 0.5% deoxycholate, 0.1% SDS,
1 mM phenylmethylsulfonyl fluoride, protease inhibitor cocktail
and phosphatase inhibitor cocktail) and centrifuged, subsequently,
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10% or 12.5% polyacrylamide gels electrophoresis and transferred
to PVDF membranes. Non-specific binding on the membranes
was blocked by 5% w/v non-fat milk in TBST (TBS containing
0.1% Tween-20) for 1 h to prevent non-specific binding. Primary
antibodies were diluted in TBST and incubated with the
membrane as follows: tau pT231 (1:4000), tau pS396 (1:4000),
tau pS205 (1:2000), tau pS404 (1:3,000), pan-tau (1:4000),
phosphorylated ERK (1:2000), total ERK (1:4000), phosphorylat-
ed JNK (1:2000), total JNK (1:4000), synapsin-1 (1:40,000),
synaptophysin (1:40,000), PSD95 (1:2000), APP (1:5000), sAPPa
(1:500), sAPPb (1:500), acetylated-tubulin (1:40,000). After wash-
ing, the membranes were incubated with horseradish peroxidase-
conjugated secondary antibodies for 1 h and subsequently
developed by using the ECL or ECL-plus Western blotting
detection kit. The membranes were then stripped with stripping
buffer (50 mM glycine, 2% SDS, pH 2.0) and re-probed with anti-
a-tubulin antibody (1:40,000) and goat anti-mouse HRP second-
ary antibody. Optical density of the blots was measured with
Image J software (National Institutes of Health, USA). The band
intensities were normalized against a-tubulin and results were
expressed as fold of control.
Statistical analysis
Data were expressed as mean 6 standard error (SE). The
significance of the differences among different groups was
determined by unpaired t-test. All statistical analyses were
performed using SigmaStatH (Jandel Scientific, CA, USA).
P,0.05 was considered to be statistically significant.
Results
Passive cigarette smoking induced oxidative stress in the
rat hippocampus
It has been found that passive cigarette smoking can induce
oxidative stress in both the peripheral circulation and in the
central nervous system (CNS) [17,24]. The first part of this study
was to confirm the presence of oxidative stress in the hippocampus
of the rats which had been exposed to cigarette smoke for 56 days.
8-OHG served as a marker for oxidative stress. We found that the
immunoreactivity of 8-OHG was markedly increased in the
dentate gyrus and the CA3 regions of the hippocampus of the
smoking group (Fig. 1a to e), suggesting an elevation of oxidative
stress in these regions.
Passive cigarette smoking affects synaptic proteins in the
hippocampus
Synaptic proteins are important for the normal functioning of
synapses. To investigate the effects of smoking on synapses, we
investigated the expression of some pre-synaptic and post-synaptic
proteins. Immunohistochemical staining revealed that the level of
pre-synaptic protein synapsin-1 was markedly reduced as demon-
strated by the reduction of fluorescent intensity (Fig. 2a to d). The
result was confirmed by Western blot analysis (Fig. 2e and f) which
showed that the level of synapsin-1 decreased to 0.3860.03 fold of
control in the smoking group. We also detected the level of
synaptophysin (Fig. 2g), which is another pre-synaptic protein. The
band intensity of synaptophysin decreased to 0.7360.03 fold of
control in the smoking group (Fig. 2h). To investigate the effects of
smoking on the post-synaptic region, we detected the level of
PSD95. We found that there was no significant difference of the
levels of PSD95 between the control and smoking group (Fig. 2i
and j). To investigate the impact of smoking on spine plasticity and
stability, we performed immunohistochemical staining on drebrin,
which is found extensively in the dendritic spine responsible for
receiving excitatory inputs. The level of drebrin in the hippocam-
pus was markedly elevated (Fig. 3a and b). The fluorescent
intensity in the smoking group increased to 1.6260.11 fold of
control (Fig. 3c). Western blot analysis showed a trend of increase
in band intensity, although it was not statistically significant (Fig. 3d
and e). Our data suggested that smoking could have impact on
both the pre-synaptic and the post-synaptic regions.
The level of acetylated-tubulin was decreased in the
smoking group
Since smoking may also affect other cellular functions such as
the motor-based trafficking system, we detected the levels of
acetylated a-tubulin which can affect the binding affinity of
kinesin-1. The immunoreactivity of acetylated-tubulin was mark-
edly decreased in the CA1 and CA3 regions of the hippocampus in
the smoking group (Fig. 4a to d). Quantitative analysis of the
Western blot results suggested that the level of acetylated-tubulin
in the smoking group was just 0.5960.03 fold of the control group
(Fig. 4e and f). This alteration of acetylation levels of a-tubulin
might imply an impairment of cellular transport system.
Figure 1. Level of 8-OHG was elevated in rat hippocampus
exposed to cigarette smoking. Brain sections were stained with
anti-8-OHG antibody to detect the level of oxidative stress. Represen-
tative photos were selected from the control group (a and c) and the
smoking group (b and d), magnification, 100X. An enlarged photo of
the CA3 region of the smoking group was shown in (e), magnification,
400X.
doi:10.1371/journal.pone.0036752.g001
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tau in the hippocampus
The change in levels of acetylated-tubulin made us suspect that
smoking might have other effects on the cellular transport
machinery. The level of phosphorylation can affect the binding
affinity of tau to microtubules (MTs), hence the stability of the
cytoskeleton. We examined some phosphorylation sites of tau in
the hippocampus of our rats. Western blots developed with pan-
tau (K9JA) antibody indicated that the total tau level was not
altered by smoking (Fig. 5a). Phosphorylation of tau was detected
Figure 2. Levels of the pre-synaptic proteins were decreased in the hippocampus of the smoking group. Brain sections were stained
with anti-synapsin-1 antibody. The CA3 region of (a) control group and (c) smoking group were shown, magnification, 200X; with corresponding
enlarged images shown in (b and d), magnification, 400X. Western blot analysis was performed on the total lysate of the whole hippocampus,
confirming the decrease of synapsin-1 in the hippocampus of the smoking group (e); quantitative analysis of the band intensity of synapsin-1 was
shown in (f). Western blot analysis showed that the levels of synaptophysin in the hippocampus were decreased in the smoking group (f);
quantitative analysis of the band intensity of synaptophysin was shown in (g). Western blot analysis showed that the levels of PSD95 in the
hippocampus were similar among the two groups (h); quantitative analysis of the band intensity of PSD95 was shown in (i). *P,0.05 compared to
control.
doi:10.1371/journal.pone.0036752.g002
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site-specific tau antibodies. Among the four phosphorylation sites
we studied, smoking induced a significant increase in tau
phosphorylation at Tyr231, Tyr 205 and Ser 404 (Fig. 5a), where
the changes were 2.1960.03, 2.7060.60 and 2.4460.36 fold of
control, respectively (Fig. 5b, c, e). There was no significant
difference for the levels of phosphorylated tau at Ser396 between
the control and smoking groups (Fig. 5d).
APP processing was altered by passive cigarette smoking
Increased phosphorylation of tau and synaptic changes can be
found in AD. Hence, we further detected AD-related pathological
changes in our rats. We first detected the levels of APP but we
found that there was no change in the expression of this protein
(Fig. 6a and b). During the progression of AD, the enzymatic
cleavage of APP by a-secretase and b-secretase is altered which
results in increased productions of sAPPb and in turn, Ab peptide.
We found that rats exposed to cigarette smoke had an increased
level of sAPPbin their hippocampus, while the level of sAPPawas
unchanged compared to the control group (Fig. 6a, c and d). To
confirm if there was an increased production of Ab, we performed
immunohistochemical staining on brain sections using the anti-
rodent-Ab antibody. The level of Ab was markedly increased in
the smoking group, particularly in the CA3 region. In the control
animals, there was very little staining of Ab in CA3 (Fig. 6e), but
Ab accumulated in the cell body in the smoking group (Fig. 6h). In
the dentate gyrus, the basal level of Ab in the control group (Fig. 6f
and g) was higher than that in the CA3, but even then we could
still detect an elevation in the staining of Ab in the smoking group
(Fig. 6i and j). Our results suggested that smoking could alter APP
processing and direct it to the amyloidogenic pathway to favor the
generation of Ab peptide.
Stress kinases were activated by passive cigarette
smoking
Since passive cigarette smoking induced oxidative stress in our
model, we further detected the possible activation of some stress
kinases. Western blot analysis revealed that the level of p-ERK1/2
was increased to 2.4260.48 fold of control, while the level of total
ERK was unchanged (Fig. 7a and b). The level of p-JNK was also
increased. The band intensity of the smoking group was increased
to 1.8760.23 fold of control (Fig. 7c and d). The levels of p-
GSK3b (Ser9) (which represents the inactivation of kinase activity),
p-GSK3b (pY216) (which represents the activation of kinase
activity) and p-PP2A (pY307) were found to be similar among the
control and the smoking groups (Fig. 7e to h). There was also no
change in the levels of cleaved caspase-3 (Fig. 7i and j).
Discussion
Cigarette smoking is a well-reported aging accelerator. The
impact of smoking is reflected on both the reduction of lifespan
and the increased susceptibility to diseases such as cardiovascular
diseases, cancers and respiratory complications. Both active and
passive smoking are associated with cognitive decline and AD
[1,3–6], yet the biological mechanism is not well characterized. In
this study, we examined the pathological changes in the
hippocampus of cigarette smoke-exposed rats. This model aims
to imitate the situation of humans in restaurants or bars where
cigarette smoking is permitted [22]. Our data suggested that daily
exposure to cigarette smoke could accelerate the aging of the brain
Figure 3. Level of drebrin was increased in the smoking group. Brain sections were stained with anti-drebrin antibody. The CA3
region of the control (a) and smoking (b) group were shown, magnification, 100X. Western blot analysis showed that there was a trend of increase in
the band intensity of drebrin but it is not statistically significant (c and d).
doi:10.1371/journal.pone.0036752.g003
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neuropathology.
The induction of oxidative stress is a major mechanism for
cigarette smoke to impose its deleterious effects. It has been found
that smokers have lower serum levels of antioxidants (ascorbic
acid, a-carotene, b-carotene, cryptoxanthin, melatonin), anti-
oxidative enzymes (selenium glutathione peroxidase, glutathione
reductase) and higher levels of oxidative stress markers (mal-
ondialdehyde) [25–27]. This systemic oxidative stress explains why
cigarette smoke has effects on multiple organs. Previous studies on
human subjects confirm the increased free radical damage in the
cerebral cortex in both smoker and AD patients [28]. A recent
study also demonstrated the importance of oxidative stress by
showing that Vitamin E can attenuate cigarette-smoke induced
elevation of acetylcholinesterase activity and lipid peroxidation
level in rat brains [29]. Therefore, we first characterized our
model to confirm the presence of oxidative stress in the
hippocampus of cigarette smoke-exposed rats. We used an
antibody which could stain for 8-hydroxy-29-deoxyguanosine (8-
OHdG) and 8-hydroxyguanosine (8-OHG) to indicate the
presence of oxidative stress. 8-OHdG and 8-OHG are generated
when the guanine of DNA and RNA are oxidized by reactive free
radicals respectively [30]. Studies have shown that the levels of 8-
OHG and 8-OhdG are increased in vulnerable neurons of patients
with AD, furthermore, the concentration of 8-OHdG in the CSF
of AD patients was positively correlated with the duration of illness
[31–33]. Our data showed that the level of 8-OHG was increased
in the smoking group. This data is consistent with a report showing
elevation of oxidative stress in the hippocampus of 60-day cigarette
smoke-exposed mice [17]. Although another study conducted by
Fuller and colleagues showed no change in oxidative stress levels in
the brain of cigarette smoke-exposed rats [34], we believe the
experimental protocol which determined the amount of cigarette
smoke being taken was responsible for the observed discrepant
findings. In their study, rats were exposed to cigarette smoke 3 h
daily for 3 weeks to mimic airborne exposure as experienced in a
household room, with a smoker consuming two cigarettes per hour
over 10 h. While apoptotic cell death and increased activities of
capsase-3 were found in their model, our model did not induce
activation of caspase-3 nor neuronal cell loss as revealed by Nissl
staining (data not shown). Data from human autopsy samples
Figure 4. Level of acetylated-tubulin was decreased in the
hippocampus of the smoking group. Brain sections were stained
with anti-acetylated-tubulin antibody. The CA1 and CA3 regions of
control group (a and b), smoking group (c and d) were shown,
magnification, 200X. Western blot analysis confirmed the decrease of
acetylated-tubulin in the hippocampus of the smoking group (e);
quantitative analysis of the band intensity was shown in (f). *P,0.05
compared to control.
doi:10.1371/journal.pone.0036752.g004
Figure 5. Smoking induced phosphorylation of tau. The total
lysate of the hippocampus of the rats were subjected to Western
blotting analysis. Phosphorylation of tau was detected by pT231 (reacts
with phosphorylated tau at Thr 231), pT205 (reacts with phosphorylated
tau at Thr 205), pS396 (reacts with phosphorylated tau at Ser 396) and
pS404 (reacts with phosphorylated tau at Ser 404). Total tau was
detected with the antibody pan-tau. a-tubulin was used as loading
control. *P,0.05 compared to control.
doi:10.1371/journal.pone.0036752.g005
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white matter volume) is correlated to the number of cigarettes
consumed and smoking duration [35,36]. Thus the difference in
experimental protocol may account for the discrepancy in findings
between the two studies. Nevertheless, oxidative stress was present
in our model which is consistent with the findings in AD patients
[31–33]. Although we did not study other oxidative stress markers
in our brain samples, it was found that the activities of superoxide
dismutase and catalase, which reflect an antioxidant defense
mechanism, were significantly elevated in the lungs of the smoke-
exposed rats [23]. This further supports the induction of systemic
oxidative stress after cigarette smoke exposure.
Synaptic degeneration is an early event in neurodegenerative
diseases. Reduction in the number of synapses has been reported
in normal aging human subjects and AD patients [37] Synaptic
proteins are essential components to maintain normal synaptic
Figure 6. Smoking induced alteration of APP processing. The total lysate of the hippocampus of the rats were subjected to Western blotting
analysis. The levels of APP, sAPPa and sAPPb were detected (a); quantitative analysis of the band intensity was shown (b to d). *P,0.05 compared to
control. Brain sections were stained with anti-rodent Ab antibody. Photos of the CA1 and dentate gyrus were presented. Positive staining were
increased in the smoking group (h and i) when compared to the control group (e and f), magnification, 400X. Enlarged photos of the dentate gyrus of
the control (g) and smoking group (j) were shown. Note that Ab was accumulated in the cell body (j).
doi:10.1371/journal.pone.0036752.g006
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protein and is often used as a marker for quantifying the number
of intact synapses. Synaptophysin interacts with other synaptic
proteins such as synaptobrevin to control the exocytosis of synaptic
vesicle, hence the release of neurotransmitters [38]. Synapsin-1 is
another presynaptic protein which regulates neurotransmitter
release. Through changing its state of phosphorylation, synapsin-1
controls the fraction of synaptic vesicles available for release [39].
Our data showed that chronic exposure to cigarette smoke
decreased the expression of synapsin-1 and synaptophysin, which
Figure 7. Smoking induced activation of stress kinases. The total lysate of the hippocampus of the rats were subjected to Western blotting
analysis. The levels of p-ERK1/2, total ERK1/2 (a), p-JNK and total JNK (b), p-GSK3b (Ser9), p-GSK3b (pY216), p-PP2A (pY307) (e) and cleaved caspase-3
(i) were detected. a-Tubulin was used as loading control. Quantitative analysis of the band intensity of the detected kinases was shown in (b, d, f–g,
and j). *P,0.05 compared to control.
doi:10.1371/journal.pone.0036752.g007
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increase in the expression of drebrin, a protein which is localized
at the dendritic spine. Actin filaments are the major cytoskeletal
component in dendritic spine. Drebrin can bind to actin and
inhibit its interaction with myosin, resulting in reduction of
contractile force of actomyosin and thereby inhibit spine
retraction. Overexpression of drebrin has been shown to alter
spine shape [40,41]. Since morphological changes of spines are
highly correlated to synaptic plasticity, it is possible that the
increased expression of drebrin would affect normal synaptic
functions. Dysregulation of drebrin expression has been found in
AD patients and subjects with mild cognitive impairment [42,43].
In fact, a recent study has shown that the expression of drebrin was
increased in aged-rats with cognitive impairment but not altered in
aged-rats without cognitive impairment [44]. It has been proposed
that increased expressions of drebrin may have inhibitory effects
on activity-responsive reorganization of spine structure, leading to
a maladaptive rigidity of synaptic structure that could affect
synaptic plasticity [44]. Hence, our data on synaptophysin,
synapsin-1 and drebrin suggest that chronic exposure to cigarette
smoke leads to synaptic changes which are related to aging and
cognitive impairment.
Tubulin is the basic component of the MTs. Acetylation of a-
tubulin is important for axonal transport and acetylated-tubulin is
found on stable MTs. Kinesin-1, a motor protein which supports
cargo-transport, can bind to MTs only when a-tubulin is
acetylated [45]. Reduction of acetylated-tubulin has been reported
in neurofibrillary tangle bearing neurons of AD patients [46]. We
found that the level of acetylated-tubulin in cigarette-smoke
exposed group was about 40% less than that in the control group,
suggesting a possible impairment of axonal transport. More
functional studies may be required to confirm this issue. Apart
from the possible alteration of cellular transport machinery, the
reduction of acetylated-tubulin may also reflect a decreased level
of stable or mature MTs. The tau protein is a MT-associated
protein which plays major role in promoting assembly and stability
of MTs and vesicle transport. Hyperphosphorylated tau proteins
lack the affinity to MTs and they are prone to self-associate into
paired-helical filament structure and aggregates to form neurofi-
brillary tangles [47]. In our study, chronic exposure to cigarette
smoke induced hyperphosphorylation of tau at Thr 231, Thr 205
and Ser 404. These changes can affect the normal functions of tau,
leading to reduced stability of microtubule as reflected by the
reduction of acetylated-tubulin.
The phosphorylation state of tau is determined by tau kinases
and phosphatase such as GSK3b, CDK5, ERK1/2, JNK and
PP2A [48]. We found that the levels of p-ERK1/2 and p-JNK
were elevated in the hippocampus of the smoking group. We also
detected the levels of p-GSK3b (Ser9), p-GSK3b (Tyr216) and p-
PP2A (pY307) and found that their levels remained unchanged.
The kinase(s) responsible for hyperphosphorylation of tau in our
model is unclear. We proposed that hyperphosphorylation of tau
by passive cigarette smoking could be a consequence of oxidative
stress-mediated JNK and ERK activation. It has been shown that
oxidative stress can activate ERK and JNK [49,50], and the
activation of these kinases can phosphorylate tau at Thr 231, Thr
205 and Ser 404 [48,51]. Many components of cigarette smoke are
potent oxidant. Nicotine, for example, has been shown to induce
reactive oxygen species in rat mesencephalic neurons [52].
Chronic administration of nicotine to transgenic AD mice can
exacerbate tau pathology [53]. As the level of 8-OHG was
increased in the smoking group in our model, the oxidative stress
being produced can be one of the activator for JNK and ERK,
which in turns phosphorylated tau.
Oxidative stress may participate in the pathogenesis of AD
through modulating APP processing. In vitro studies have shown
that oxidative stress can modulate the activities of b- and c-
secretases and promote the production of Ab through a JNK-
dependent pathway [54,55]. In our study, we detected an increase
in immunoreactivity of Ab in brain sections of the smoking group.
This staining was performed by using an antibody which reacts
with all isoforms of rodent Ab but not human Ab. It is possible that
our Ab staining did not result from Ab peptide only but also from
APP. However, we have shown that the level of APP remains
unchanged between the control and smoking groups. It is
therefore unlikely that the elevated levels of Ab immunoreactivity
were due to increased expressions of APP. The level of sAPPa
(produced by a-secretase) was unchanged and that of sAPPb
(produced by b-secretase) was increased. Whether cigarette smoke
affects the expression of the a- and b-secretases or alters their
activities deserves further studies. Ab toxicity plays a central role in
the development of AD. Ab peptide can induce synaptic
degeneration and impairment of axonal transport [56]. Recent
papers show that Ab decreases acetylation of a-tubulin [57,58]. It
is likely that the Ab induced by cigarette smoke is partly
responsible for the observed reduction of acetylated-tubulin and
synaptic changes.
This study has demonstrated that chronic exposure to cigarette
smoke induced changes in synaptic proteins, changes in the
dynamic of cytoskeleton and pre-AD-like neuropathology. Because
we did not study the cognitive functions in these rats, we are not
able to tell if these neuronal changes are directly linked to
cognitive impairment. However, it is worth to note that the
changes we observed may only reflect early pathological changes
in pre-symptomatic stage, so cognitive impairment might not
necessary appear. Senile plaques and neurofibrillary tangles were
also absent in our model (data not shown). After all, cigarette
smoke is only a risk factor for AD, the development of the disease
can be affected by other factors such as midlife hypertension,
physical inactivity and genetic factors. Smoking alone is unlikely to
induce AD. We have no intention to claim that exposure to
cigarette smoke can result in AD. Epidemiological studies suggest
that the second largest number of AD cases worldwide was
potentially attributed to smoking [59]. With this evidence in mind,
we aimed to find out some early changes in the brain after
cigarette-smoke exposure. These changes, such as phosphorylation
of tau in several epitopes, do not represent a harmful event to the
neurons if they occur alone. However, many abnormalities were
observed in the hippocampus in the smoking-exposed rats and
these changes collectively may have an impact in normal cellular
functions. To conclude, our study demonstrated that exposure to
cigarette smoke could induce pathological changes in the brain,
and these changes might make us more susceptible to the
development of cognitive impairment or even AD in late life.
Further study is conducting to confirm the importance of oxidative
stress in the process.
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